Abstract
Dual antiplatelet therapy (DAPT) with aspirin and clopidogrel is often prescribed after lower extremity endovascular interventions. However, some patients can have disease resistant to clopidogrel, which has been termed “high on-treatment platelet reactivity” (HoTPR). Patients with HoTPR during clopidogrel therapy might have an increased risk of intervention failure. We compared different antiplatelet prescribing strategies after lower extremity femoropopliteal endovascular interventions using cost-effectiveness modeling.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
